Announcements

7 January 2025
MDPI INSIGHTS: The CEO's Letter #19 - Reflecting on 2024, Society Journals, OA Germany

Welcome to the MDPI Insights: The CEO's Letter.

In these monthly letters, I will showcase two key aspects of our work at MDPI: our commitment to empowering researchers and our determination to facilitating open scientific exchange.


Opening Thoughts

Reflecting on 2024: Celebrating Our Progress and People

As we reflect on the year gone by, I’m proud and thankful for what we’ve accomplished together. This has been a year of growth, learning, and resilience, all of which have shaped MDPI’s journey. I would like to thank each of our employees for their dedication, hard work, and commitment to advancing open access (OA) publishing.

Our growth is evident: from about 5,900 colleagues at the end of 2023 to over 6,650 today, our global MDPI community continues to expand. We expanded our global operations with a new office in Seoul, South Korea, and celebrated a record-breaking year with 60 MDPI journals newly indexed in the Web of Science and 37 MDPI journals accepted into Scopus. As at 30 December, 2024, we publish 457 journals, of which 448 are peer-reviewed and 9 dedicated to academic conference outputs. Of these, 306 are indexed in Scopus, 298 in the Web of Science, and 90 in PubMed.

Looking for a new role in 2025? We have a variety of roles currently open!

Yet, growth never comes without its challenges. This year, we faced setbacks, including the removal of the Journal of Personalized Medicine from the Web of Science due to content relevance concerns. Our editorial and research integrity teams are actively addressing these issues, and we aim to reapply for indexation in December 2026. On another front, the decision by JUFO, The Finnish Publication Forum, to downgrade many MDPI journals presented a challenge. However, we are engaging with the Finnish research community and our editorial boards to provide scientific data supporting a reevaluation of MDPI journals in alignment with Finland’s national open access policies.

These examples remind us that challenges are part of our journey. What defines us is how we respond, by learning, adapting, and improving our practices and operations.

On the partnerships front, we achieved a landmark national open access agreement with over 100 German universities, effective 1 January 2025, bringing our total of Institutional Open Access Program (IOAP) partners to over 950. These achievements reflect not just our ambition but also the trust placed in MDPI by our collaborators worldwide.

Amidst growth and change, one constant remains: the people of MDPI. This year, I had the privilege of representing MDPI at important meetings and conferences from Beijing to Krakow, while visiting many of our offices, from Tokyo and Cluj to Manchester and Toronto. The highlight of my year has been meeting and connecting with so many of you.

“MDPI thrives because of community and collaboration”

When asked what makes MDPI a great place to work, my answer is simple: It’s the people. Our authors frequently praise the support and professionalism of our editorial staff. That same care extends inward, reflected in the friendships and collaborations we regularly nurture with our colleagues. MDPI thrives because of the community and collaboration that drives us forward.

As the African proverb states, “If you want to go fast, go alone. If you want to go far, go together.” I believe MDPI embodies both, being speedy in our daily operations and united in our purpose of promoting open access publishing.

Looking ahead to 2025, let us continue building a culture of care and support for one another, take pride in our work, and strive to improve all that we do. Thank you for making 2024 a special year, and I look forward to what we can achieve together in 2025.

PS: I look forward to sharing more about our people and the achievements of the past year in the 2024 Annual Report.

Impactful Research

685 MDPI Editors Named Highly Cited Researchers in 2024

I’m excited to celebrate the achievements of 685 Editorial Board Members (EBMs) from our journals, representing 39 countries and territories, who have been named Highly Cited Researchers for 2024 by Clarivate. This prestigious recognition highlights their scientific contributions, which transcend academic boundaries to drive progress in global knowledge, sustainability, security, and well-being.

Here, you’ll find the list of MDPI’s EBMs who have been recognized this year.

Clarivate’s annual Highly Cited Researcher™ list identifies the most influential scientists of the past decade – those whose work has made a profound and far-reaching impact across numerous scientific and social science disciplines. To be included on this list is no small feat. These researchers’ impactful papers rank among the top 1% by citations in one or more of the 21 fields analyzed within the “Essential Science Indicators,” positioning them as leaders in their domains.

As Clarivate notes, “Highly Cited Researchers have demonstrated significant and broad influence in their field(s) of research.” In 2024, a total of 6,886 Highly Cited Researcher designations were awarded to 6,636 individuals globally.

I extend my congratulations to all of MDPI’s EBMs who have achieved this milestone. Their dedication and excellence inspire us all and exemplify the high standards we uphold as a publisher. Congratulations to each of them for this incredible accomplishment and for their ongoing contributions to advancing knowledge in their fields.

Inside MDPI

How MDPI / Open Access Supports Societies

MDPI actively supports societies through the launch of new journals, the acquisition of established journals, and the transfer of society journals from other publishers. You can submit your proposal here.

Over the past 13 years, we have collaborated with over 190 learned societies and organizations. These partnerships range from affiliations with one or more of our journals to publishing journals on behalf of our partners.

Learn about how MDPI / Open Access Supports Societies.

In this section I highlight our Societies team, whose responsibilities include establishing new OA journals on behalf of societies and institutions, publishing an existing OA journal with MDPI or transitioning a subscription journal to an OA model, and establishing affiliations between societies and MDPI journals.

If you would like to learn more about these services, please see the Societies website.

The Societies team is led by Dr. Carla Aloè, Head of Societies and Acquisition, and her Deputy Manager, Dr. Clàudia Aunós. MDPI collaborates with a wide range of societies through various partnerships. For a complete list of collaborating societies and society journals, please visit the Societies website.

How long have you been at MDPI, and what was your first role?

I joined MDPI in September 2020 as an Associate Publisher and Scientific Officer, overseeing the Arts, Humanities, and Social Science journals. In July 2022, I took on the oversight of the Society and Acquisition team. 

Do you think that perceptions of Open Access are generally accurate?

Far from it: there are in fact many misconceptions surrounding the way Open Access works and the benefits it has to offer. A common misconception is that OA journals are poor quality, which is entirely untrue. Many of our journals are included in major indexing databases, and all of them are endorsed by prominent associations and committees such as the Committee on Publication Ethics (COPE), the International Association of Scientific, Technical, and Medical Publishers (STM), and the Open Access Scholarly Publication Association (OASPA). We uphold a rigorous peer-review process, adhere to strict ethical standards, and rely on high-profile editorial boards. 

How long have you been at MDPI, and what was your first role?

I’ve been at MDPI for almost seven years now. I started as an Assistant Editor but was quickly promoted to work with societies.

What is the most common question you get asked about the services that the Societies team provides?

For societies with a standard number of members (less than 500), the most common inquiry is about how much the publishing services we offer cost. One of the great things about our publishing services is that they are free of any burden cost to the society, regardless of the type of non-profit organization.  

For bigger non-profit organizations, it is more about what benefits they can get for their members and ensuring that their journals are in good hands.

Either way, the goal is the same: to listen to the demands of the market, be flexible, and help our partners achieve healthy and positive development of their journals.

Read more:

Coming Together for Science

2024 MDPI Conference Summary

Throughout 2024, the MDPI Conference Team connected with scientific communities by organizing nine in-person events and 26 virtual conferences. In order to support the need for our growing events, we expanded this team to a total of 37 people across all offices, including 18 members in Asia-Pacific and 20 in the EU and North America.

The nine large-scale in-person conferences organized brought together leading minds across diverse disciplines, including our conferences on Viruses, Molecules, Polymers, Materials, Non-Coding RNA, Pharmaceuticals, and Sensors. These events strengthened synergies with the scientific community, actively promoting our journals and the latest research published within their respective fields. These achievements highlight our Conference Team’s dedication to creating meaningful and memorable events in the academic field.

2024 Event Highlights

Viruses 2024, the 5th edition of the conference series, hosted influential keynote speeches from Nobel Prize laureate Dr. Charles M. Rice and ‘Distinguished Senior Virologist’ Prof. Luis Enjuanes. The event attracted 240 attendees from around the globe. With 47 talks and nearly 130 poster presentations, the conference explored the latest developments in viral pathogenesis and immune responses across six engaging sessions.

Molecules 2024, the fourth edition of this conference series, highlighted the impact of emerging drug modalities on drug discovery. The event brought together over 100 attendees from 22 countries and featured more than 80 submissions organized into six sessions. The program included talks by 12 invited speakers from Europe, Asia and the United States. An impressive 97% of attendees rated the conference as ‘Excellent’ or ‘Good.’

Polymers 2024, attracted over 300 attendees from 22 countries and featured 259 accepted abstracts. Focusing on green polymer chemistry and the use of bioresources, the conference highlighted advancements in the synthesis of biobased and biodegradable polymers. Engaging lectures by three keynote speakers and 12 invited speakers, coupled with dynamic discussions, led 94% of attendees to rate the conference as ‘Excellent’ or ‘Good.’

A high-profile summit in Toronto was organized by the team, which expanded our global reach and showcased our capacity to deliver impactful events in our different offices. Sixteen EiC and seven EBMs joined our event, and with a 100% rate of Excellent/Good, over 90% of them said they are likely to attend our next edition.

The 1st International Conference on AI Sensors & The 10th International Symposium on Sensor Science successfully gathered about 400 participants onsite. Three hundred and fifty-five abstracts were accepted, with 772 authors from 28 countries. Across the four-day program, there were 296 talks delivered and 66 posters displayed.

The 2nd Sustainable Publishing Forum was successfully held in Beijing, China, with around 120 attendees from local publishers, editorial staff from local university presses, librarians, etc. The event is focused on promoting open science, maintaining research integrity and fulfilling social responsibility.

ICM 2024, the 5th International Conference on Materials, brought together scientists, researchers and industry leaders to explore advancements in materials characterization, processing and manufacturing. Topics ranged from nanotechnology and biomaterials to energy materials and AI-driven research. With 62 attendees from 26 different countries, the program featured 34 talks and 18 posters, fostering collaboration and innovation over 2.5 days.

The second edition of ncRNA 2024 welcomed 104 attendees from 30 countries, 71% of them being women. Two keynote speakers, Prof. Ling-Ling Chen and Prof. Mauro Giacca, shared insights drawn from over 10 years of experience. Prof. Giacca's groundbreaking work promises advances in curative therapies for heart failure, while Prof. Chen’s team continues to lead the development of the ncRNA field. High participant engagement generated valuable topics for future editions, and 96% of attendees rated the conference as ‘Excellent’ or ‘Good’.

Pharmaceuticals 2024, with its eight sessions, covered the newest technologies and the research areas of medicinal chemistry, natural products, organic synthesis, radiopharmaceuticals, pharmacology, toxicology, and biomolecular and glycosciences, among others. The conference featured three plenary and eight invited speakers, comprising esteemed scholars from eight different countries of Europe, and welcomed 64 participants from 28 different countries. Ninety-one percent of the attendees rated the conference as ‘Excellent’ or ‘Good’, highlighting the outstanding organzation of the event.

In 2024, we organized 26 virtual events with an average submission number of 158 abstracts per event, and an average registration number of 491 per event. Compared with the last edition, we saw a 42.2% growth of accepted abstract submissions.

The year 2024 marked a change in the strategy of our conference team, prioritizing the improvement of the communication and collaboration within our European and Asia-Pacific teams and creating stronger teamwork to elevate the quality and impact of MDPI events.

Scheduled Events in 2025

Closing Thoughts

Over 100 German Universities Partner with MDPI in New National Agreement  

I am pleased to share some exciting end-of-year news: MDPI has reached a major milestone by signing a publishing agreement with over 100 German universities and research institutions! Negotiated by ZB MED - Informationszentrum Lebenswissenschaften, the agreement came into effect on 1 January 2025 and will run until the end of 2026.

This new cooperation aims to make scientific Gold Open Access publishing more affordable and less administratively burdensome for researchers in Germany.

Learn more, here.

“Thank you to everyone who contributed to making this agreement a reality.”

Why is this important?

Germany is a global leader in academic research and publishing, ranking fifth in total MDPI publication volume.

This agreement reflects our growing influence and leadership in open access publishing.

Partnering with more than 100 institutions highlights MDPI’s reputation as a trusted publishing partner for the academic community.

As Peter Roth, MDPI Head of Publishing, noted:

“MDPI can look back on over a decade of successful partnerships with German research institutions. This agreement marks another milestone in our collaboration with the German scientific community.” 

Adrian Stefan Zamfir, Institutional Partnership Manager for the DACH region, added:

“We are delighted that this agreement will give even more researchers in Germany access to our tried-and-tested and reliable publication platform” 

Thank you to everyone who contributed to making this agreement a reality. This milestone reinforces MDPI as a trusted leader in advancing open access and supporting researchers worldwide.

Stefan Tochev
Chief Executive Officer
MDPI AG

More News...
Back to TopTop